{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:38:44Z","timestamp":1785544724499,"version":"3.56.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100020940","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-102035"],"award-info":[{"award-number":["HL-102035"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015982","name":"Midwest Athletes Against Childhood Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jtha.2023.07.025","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T20:46:43Z","timestamp":1691441203000},"page":"23-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond"],"prefix":"10.1016","volume":"22","author":[{"given":"Saurabh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn A.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.07.025_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/781857","article-title":"Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis","volume":"2014","author":"Ghoshal","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.jtha.2023.07.025_bib2","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1538-7836.2009.03586.x","article-title":"2009 Platelet Colloquium Participants. Platelet functions beyond hemostasis","volume":"7","author":"Smyth","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib3","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/j.2040-4603.2015.tb00649.x","article-title":"Platelets and their interactions with other immune cells","volume":"5","author":"Lam","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jtha.2023.07.025_bib5","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3389\/fimmu.2020.01962","article-title":"Crosstalk between platelets and microbial pathogens","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCRESAHA.121.319821","article-title":"Platelet and megakaryocyte roles in innate and adaptive immunity","volume":"130","author":"Koupenova","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2023.07.025_bib7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/JLB.MR0718-261RR","article-title":"Megakaryocytes as immune cells","volume":"105","author":"Cunin","year":"2019","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jtha.2023.07.025_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/09537104.2019.1693035","article-title":"Megakaryocyte emperipolesis: a new frontier in cell-in-cell interaction","volume":"31","author":"Cunin","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2023.07.025_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44031","article-title":"Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets","volume":"8","author":"Cunin","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jtha.2023.07.025_bib10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.addr.2010.06.007","article-title":"Platelets as delivery systems for disease treatments","volume":"62","author":"Shi","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtha.2023.07.025_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.omtm.2018.01.011","article-title":"Platelet-targeted gene therapy for hemophilia","volume":"9","author":"Shi","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jtha.2023.07.025_bib12","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1111\/jth.12938","article-title":"Platelet-delivered therapeutics","volume":"13","author":"Lyde","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/mt.2015.20","article-title":"Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A","volume":"23","author":"Wang","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2023.07.025_bib14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1182\/blood-2015-07-607937","article-title":"Megakaryocyte- and megakaryocyte precursor-related gene therapies","volume":"127","author":"Wilcox","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1096-7192(03)00049-0","article-title":"Expression of human factor VIII under control of the platelet-specific alphaIIb promoter in megakaryocytic cell line as well as storage together with VWF","volume":"79","author":"Shi","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jtha.2023.07.025_bib16","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/blood-2003-05-1519","article-title":"Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment","volume":"102","author":"Yarovoi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib17","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1172\/JCI28416","article-title":"Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies","volume":"116","author":"Shi","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.07.025_bib18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3389\/fimmu.2020.00964","article-title":"Platelet-targeted FVIII gene therapy restores hemostasis and induces immune tolerance for hemophilia A","volume":"11","author":"Cai","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/mt.2013.197","article-title":"Platelet gene therapy by lentiviral gene delivery to hematopoietic stem cells restores hemostasis and induces humoral immune tolerance in FIX(null) mice","volume":"22","author":"Chen","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2023.07.025_bib20","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/jth.13800","article-title":"Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated","volume":"15","author":"Chen","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib21","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1038\/ncomms3773","article-title":"Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A","volume":"4","author":"DU","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2023.07.025_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/jth.12633","article-title":"In\u00a0vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection","volume":"12","author":"Schroeder","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib23","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/bloodadvances.2020004071","article-title":"Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity","volume":"5","author":"Schroeder","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.07.025_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1538-7836.2007.02346.x","article-title":"Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A","volume":"5","author":"Shi","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib25","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1182\/blood-2008-02-138214","article-title":"Syngeneic transplantation of hematopoietic stem cells that are genetically modified to express factor VIII in platelets restores hemostasis to hemophilia A mice with preexisting FVIII immunity","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib26","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2009-11-255612","article-title":"Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2023.07.025_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.675897","article-title":"Challenges posed by immune responses to AAV vectors: addressing root causes","volume":"12","author":"Hamilton","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib29","doi-asserted-by":"crossref","first-page":"e9958","DOI":"10.15252\/emmm.201809958","article-title":"Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives","volume":"11","author":"Naldini","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jtha.2023.07.025_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/hae.14530","article-title":"Gene therapy - are we ready now?","volume":"28","author":"Kaczmarek","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.07.025_bib31","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1538-7836.2012.04791.x","article-title":"Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity","volume":"10","author":"Kuether","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib32","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/bloodadvances.2019000516","article-title":"Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice","volume":"3","author":"Gao","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.07.025_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet\u00a0alpha-granules: basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2023.07.025_bib34","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/jth.13147","article-title":"Platelet secretory behaviour: as diverse as the granules ... or not?","volume":"13","author":"Heijnen","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib35","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI108246","article-title":"Cytochemical localization of lysosomal enzymes in rat megakaryocytes and platelets","volume":"56","author":"Bentfeld","year":"1975","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.07.025_bib36","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.07.025_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1160\/TH03-07-0440","article-title":"Autologous platelets as a source of proteins for healing and tissue regeneration","volume":"91","author":"Anitua","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1089\/10799900260286623","article-title":"Role of blood platelets in infection and inflammation","volume":"22","author":"Klinger","year":"2002","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.jtha.2023.07.025_bib39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2023.07.025_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrm2871","article-title":"The final steps of integrin activation: the end game","volume":"11","author":"Shattil","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jtha.2023.07.025_bib41","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MOH.0b013e3283632e6b","article-title":"Advances in platelet granule biology","volume":"20","author":"Koseoglu","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jtha.2023.07.025_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fcvm.2020.00015","article-title":"Procoagulant phosphatidylserine-exposing platelets in\u00a0vitro and in\u00a0vivo","volume":"7","author":"Reddy","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2023.07.025_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between platelets and coagulation","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2023.07.025_bib44","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1161\/01.RES.0000267878.97021.ab","article-title":"Adhesion mechanisms in platelet function","volume":"100","author":"Ruggeri","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2023.07.025_bib45","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0049-3848(10)70151-1","article-title":"Platelet adhesion to collagen","volume":"127","author":"Nuyttens","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.07.025_bib46","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI115144","article-title":"Thrombospondin-induced adhesion of human platelets","volume":"87","author":"Tuszynski","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.07.025_bib47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2004-12-4856","article-title":"Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13","volume":"107","author":"Bonnefoy","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib48","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1538-7836.2006.01943.x","article-title":"Role of fibronectin assembly in platelet thrombus formation","volume":"4","author":"Cho","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fmed.2018.00317","article-title":"The platelet response to tissue injury","volume":"5","author":"Eisinger","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtha.2023.07.025_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.V65.1.85.85","article-title":"Von Willebrand factor in the vessel wall mediates platelet adherence","volume":"65","author":"Stel","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.ATV.6.1.24","article-title":"Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells","volume":"6","author":"Houdijk","year":"1986","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jtha.2023.07.025_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2516.2008.01848.x","article-title":"Function of von Willebrand factor in haemostasis and thrombosis","volume":"14","author":"Reininger","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.07.025_bib53","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1473-0502(03)00044-2","article-title":"Platelets in hemostasis and thrombosis: role of integrins and their ligands","volume":"28","author":"Ni","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtha.2023.07.025_bib54","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/384685","article-title":"Crosstalk between platelets and the immune system: old systems with new discoveries","volume":"2012","author":"Li","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.jtha.2023.07.025_bib56","first-page":"65","article-title":"Platelets: essential components of the immune system","volume":"16","author":"Ali","year":"2015","journal-title":"Curr Trends Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2020.04.018","article-title":"Platelet-leukocyte interplay during vascular disease","volume":"307","author":"Schrottmaier","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jtha.2023.07.025_bib58","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/ATVBAHA.110.207480","article-title":"Platelet-leukocyte interactions in cardiovascular disease and beyond","volume":"30","author":"Totani","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2023.07.025_bib59","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/JLB.4MR0620-701R","article-title":"Innate immune receptors in platelets and platelet-leukocyte interactions","volume":"108","author":"Dib","year":"2020","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jtha.2023.07.025_bib60","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00018-009-0205-1","article-title":"Platelets and innate immunity","volume":"67","author":"Semple","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jtha.2023.07.025_bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0038-1669450","article-title":"The mutual relation of platelet activation and innate immunity","volume":"38","author":"Eisinger","year":"2018","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2023.07.025_bib62","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jtha.2023.07.025_bib63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/exd.13940","article-title":"Platelets are important for the development of immune tolerance: Possible involvement of TGF-beta in the mechanism","volume":"28","author":"Hotta","year":"2019","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jtha.2023.07.025_bib64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/bloodadvances.2016001453","article-title":"TGF-beta1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice","volume":"1","author":"Haribhai","year":"2016","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.07.025_bib65","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1038\/s41467-022-30444-y","article-title":"The phosphatase PTEN links platelets with immune regulatory functions of mouse T follicular helper cells","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2023.07.025_bib66","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2012-02-413526","article-title":"Thymic retention of CD4+CD25+FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia","volume":"120","author":"Aslam","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1074-7613(03)00177-8","article-title":"Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments","volume":"19","author":"Elzey","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2023.07.025_bib68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/09537104.2016.1161739","article-title":"Regulation of platelet lifespan by apoptosis","volume":"27","author":"Lebois","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2023.07.025_bib69","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1074\/jbc.M112.403154","article-title":"Regulatory role of proteasome in determination of platelet life span","volume":"288","author":"Nayak","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2023.07.025_bib70","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/infdis\/jis180","article-title":"Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections","volume":"205","author":"Alonzo","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jtha.2023.07.025_bib71","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1182\/blood-2014-08-593053","article-title":"Comparative analysis of human ex\u00a0vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib72","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/37022","article-title":"Immunosuppressive effects of apoptotic cells","volume":"390","author":"Voll","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.07.025_bib73","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1172\/JCI1112","article-title":"Macrophages that have ingested apoptotic cells in\u00a0vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF","volume":"101","author":"Fadok","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2023.07.025_bib74","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(01)00147-9","article-title":"TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu","volume":"14","author":"Chen","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2023.07.025_bib75","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.immuni.2007.11.014","article-title":"Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1","volume":"27","author":"Chung","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jtha.2023.07.025_bib76","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jth.14379","article-title":"The impact of GPIbalpha on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity","volume":"17","author":"Chen","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib77","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3389\/fimmu.2018.01950","article-title":"Platelet gene therapy promotes targeted peripheral tolerance by clonal deletion and induction of antigen-specific regulatory T cells","volume":"9","author":"Luo","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib78","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.omtn.2020.12.026","article-title":"Platelet gene therapy induces robust immune tolerance even in a primed model via peripheral clonal deletion of antigen-specific T cells","volume":"23","author":"Li","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jtha.2023.07.025_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1019275","article-title":"Hemophilia a patients with inhibitors: mechanistic insights and novel therapeutic implications","volume":"13","author":"Luo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib80","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.drudis.2021.07.015","article-title":"FVIII at the crossroad of coagulation, bone and immune biology: emerging evidence of biological activities beyond hemostasis","volume":"27","author":"Cade","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jtha.2023.07.025_bib81","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","article-title":"AAV5-factor VIII gene transfer in severe hemophilia A","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.025_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa1908490","article-title":"Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A","volume":"382","author":"Pasi","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.07.025_bib83","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/hae.13971","article-title":"Members of the WFH Gene Therapy Round Table\u00a0Program Organizing Committee. Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table","volume":"26","author":"Pierce","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.07.025_bib84","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/hae.14131","article-title":"Gene therapy to cure haemophilia: is robust scientific inquiry the missing factor?","volume":"26","author":"Pierce","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.07.025_bib85","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1182\/bloodadvances.2020002142","article-title":"Gene therapy for hemophilia: anticipating the unexpected","volume":"4","author":"Pierce","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.07.025_bib86","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.2019003777","article-title":"Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues","volume":"138","author":"Leebeek","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib87","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-med-043021-033013","article-title":"Adeno-associated virus gene therapy for hemophilia","volume":"74","author":"Samelson-Jones","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jtha.2023.07.025_bib88","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2015-08-662916","article-title":"The immunogenicity of platelet-derived FVIII in hemophilia A mice with or without preexisting anti-FVIII immunity","volume":"127","author":"Chen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib89","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1182\/blood-2017-08-742312","article-title":"Novel approaches to hemophilia therapy: successes and challenges","volume":"130","author":"Arruda","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib90","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10545-017-0053-3","article-title":"Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects","volume":"40","author":"Baruteau","year":"2017","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jtha.2023.07.025_bib91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.thromres.2017.09.018","article-title":"PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses","volume":"159","author":"Haile","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.07.025_bib92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/ijlh.12659","article-title":"Factor VIII inhibitors: advances in basic and translational science","volume":"39","author":"Lai","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2023.07.025_bib93","first-page":"46","article-title":"Treatment and prevention of bleeds in haemophilia patients with inhibitors to factor VIII\/IX","volume":"6","author":"Rocino","year":"2017","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2023.07.025_bib94","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jtha.2023.07.025_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1029356","article-title":"Targeting transmembrane-domain-less MOG expression to platelets prevents disease development in experimental autoimmune encephalomyelitis","volume":"13","author":"Cai","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib96","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41577-022-00698-0","article-title":"Immunological barriers to haematopoietic stem cell gene therapy","volume":"22","author":"Charlesworth","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2023.07.025_bib97","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jtha.2022.10.006","article-title":"Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cells","volume":"21","author":"Jing","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.07.025_bib98","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.3390\/genes13122222","article-title":"In\u00a0vivo hematopoietic stem cell genome editing: perspectives and limitations","volume":"13","author":"Psatha","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jtha.2023.07.025_bib99","first-page":"2085","article-title":"In\u00a0vivo HSC prime editing rescues sickle cell disease in a mouse model","volume":"141","author":"Li","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.07.025_bib100","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1182\/blood-2014-02-555151","article-title":"A\u00a0conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII","volume":"123","author":"Fahs","year":"2014","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:41:25Z","timestamp":1761536485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623005895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1538783623005895"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.07.025","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}